Blueprint Medicines is Tuesday's IBD Stock Of The Day. Shares are breaking a trendline, giving investors an early entry within a flat base.
On June 5, 2024, Percy Carter, Chief Scientific Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 4,000 shares of the company.
On June 4, 2024, L. Hewes, Chief Medical Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 2,424 shares of the company.